These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7594723)

  • 1. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination.
    Ward BJ; Boulianne N; Ratnam S; Guiot MC; Couillard M; De Serres G
    J Infect Dis; 1995 Dec; 172(6):1591-5. PubMed ID: 7594723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination.
    Bautista-López N; Ward BJ; Mills E; McCormick D; Martel N; Ratnam S
    Vaccine; 2000 Jan; 18(14):1393-401. PubMed ID: 10618537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles vaccination in the presence of maternal antibodies primes for a balanced humoral and cellular response to revaccination.
    Bertley FM; Ibrahim SA; Libman M; Ward BJ
    Vaccine; 2004 Dec; 23(4):444-9. PubMed ID: 15530692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of measles antibody after revaccination.
    Markowitz LE; Albrecht P; Orenstein WA; Lett SM; Pugliese TJ; Farrell D
    J Infect Dis; 1992 Jul; 166(1):205-8. PubMed ID: 1607699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and humoral immune responses to measles in immune adults re-immunized with measles vaccine.
    Wong-Chew RM; Beeler JA; Audet S; Santos JI
    J Med Virol; 2003 Jun; 70(2):276-80. PubMed ID: 12696117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for measles revaccination in adolescents: correlation with birth date prior to 1972.
    Yeager AS; Harvey B; Crosson FJ; Davis JH; Ross LA; Halonen PE
    J Pediatr; 1983 Feb; 102(2):191-5. PubMed ID: 6822921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.
    Capozzo AV; Ramírez K; Polo JM; Ulmer J; Barry EM; Levine MM; Pasetti MF
    J Immunol; 2006 May; 176(9):5671-81. PubMed ID: 16622037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of measles virus-specific neutralizing antibodies: evaluation of the syncytium inhibition assay in comparison with the plaque reduction neutralization test.
    Ward BJ; Aouchiche S; Martel N; Bertley FM; Bautista-Lopez N; Serhir B; Ratnam S
    Diagn Microbiol Infect Dis; 1999 Mar; 33(3):147-52. PubMed ID: 10092962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune response to measles vaccine in Peruvian children.
    Bautista-López NL; Vaisberg A; Kanashiro R; Hernández H; Ward BJ
    Bull World Health Organ; 2001; 79(11):1038-46. PubMed ID: 11731811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of infants given measles vaccine at 6 months of age: antibody and CMI responses to MMRII at 15 months of age and antibody levels at 27 months of age.
    Carson MM; Spady DW; Beeler JA; Krezolek MP; Audet S; Pabst HF
    Vaccine; 2005 May; 23(25):3247-55. PubMed ID: 15837229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to measles revaccination among Bolivian school-aged children.
    Bartoloni A; Cutts FT; Guglielmetti P; Brown D; Bianchi Bandinelli ML; Hurtado H; Roselli M
    Trans R Soc Trop Med Hyg; 1997; 91(6):716-8. PubMed ID: 9509188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained Responses to Measles Revaccination at 24 Months in HIV-infected Children on Antiretroviral Therapy in Kenya.
    Newman LP; Njoroge A; Magaret A; Chohan BH; Gitomea VW; Wald A; Gorstein J; Overbaugh J; Wamalwa D; Maleche-Obimbo E; Nduati R; Farquhar C
    Pediatr Infect Dis J; 2017 Dec; 36(12):1148-1155. PubMed ID: 28198789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles revaccination response in a school-age population.
    Wittler RR; Veit BC; McIntyre S; Schydlower M
    Pediatrics; 1991 Nov; 88(5):1024-30. PubMed ID: 1945606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity, immunologic memory, and safety following measles revaccination in HIV-infected children receiving highly active antiretroviral therapy.
    Abzug MJ; Qin M; Levin MJ; Fenton T; Beeler JA; Bellini WJ; Audet S; Sowers SB; Borkowsky W; Nachman SA; Pelton SI; Rosenblatt HM;
    J Infect Dis; 2012 Aug; 206(4):512-22. PubMed ID: 22693229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal IgA responses in healthy adult volunteers following intranasal spray delivery of a live attenuated measles vaccine.
    Simon JK; Ramirez K; Cuberos L; Campbell JD; Viret JF; Muñoz A; Lagos R; Levine MM; Pasetti MF
    Clin Vaccine Immunol; 2011 Mar; 18(3):355-61. PubMed ID: 21228137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Waning immunity to measles in young adults and booster effects of revaccination in secondary school students.
    He H; Chen EF; Li Q; Wang Z; Yan R; Fu J; Pan J
    Vaccine; 2013 Jan; 31(3):533-7. PubMed ID: 23159458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles vaccine failures: lack of sustained measles-specific immunoglobulin G responses in revaccinated adolescents and young adults.
    Cohn ML; Robinson ED; Faerber M; Thomas D; Geyer S; Peters S; Martin M; Martin A; Sobel D; Jones R
    Pediatr Infect Dis J; 1994 Jan; 13(1):34-8. PubMed ID: 8170730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles Virus Neutralizing Antibodies in Intravenous Immunoglobulins: Is an Increase by Revaccination of Plasma Donors Possible?
    Modrof J; Tille B; Farcet MR; McVey J; Schreiner JA; Borders CM; Gudino M; Fitzgerald P; Simon TL; Kreil TR
    J Infect Dis; 2017 Nov; 216(8):977-980. PubMed ID: 28968738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.